Research Article

Clinical Effects of Activated Charcoal Unavailability on Treatment Outcomes for Oral Drug Poisoned Patients

Table 1

Patient characteristics.

Charcoal-available periodCharcoal-unavailable periodp-value
(n=413)(n=221)

Age, median (IQR)41 (28-58)430.267
Male, n (%)148 (35.8%)770.803
Medical History
 Hypertension, n (%)72 (17.4%)32 (14.5%)0.339
 Diabetes mellitus, n (%)40 (9.7%)19 (8.6%)0.653
Multiple drug ingestion242 (58.6%)119 (53.8%)0.250
Vital signs
 Mean blood pressure (mmHg), median (IQR)93 (79-103)94 (77-107)0.495
 Heart rate (/min), median (IQR)90 (79-100)87 (76-103)0.258
 Respiratory rate (/min), median (IQR)20 (18-20)20 (18-20)0.168
 Body temperature (°C), median (IQR)36.2 (36.0-36.6)36.4 (36.0-36.7)0.102
GCS, median (IQR)14 (11-15)14 (10-15)0.971
Laboratory results
 WBC (x103/μℓ), median (IQR)7.55 (5.76-10.19)7.44 (5.96-9.82)0.996
 Hemoglobin (g/d), median (IQR)13.5 (12.6-14.6)13.4 (12.2-14.6)0.374
 Platelet (1000/μℓ), median (IQR)249 (205.5-299.5)249 (202-298.5)0.970
 Sodium (mmol/), median (IQR)139.1 (137.3-140.9)138.6 (136.6-140.6)0.046
 Potassium (mmol/), median (IQR)3.8 (3.54-4.12)3.8 (3.50-4.00)0.429
 Total CO2 (mmol/), median (IQR)22.8 (20.90-26.26)22.3 (20.15-26.50)0.082
 BUN (mg/d), median (IQR)12 (9-16)13 (11-16)0.167
 Creatinine (mg/d), median, (IQR)0.74 (0.61-0.89)0.74 (0.65-0.91)0.242
 AST (IU/), median, (IQR)25 (19-37)25 (19-28)0.880
 ALT (IU/), median, (IQR)15 (10-25)15 (10-29)0.772
 CRP (mg/d), median, (IQR)0.08 (0.03-0.24)0.07 (0.02-0.26)0.501
 CK (IU/), median, (IQR)97 (69-151)96 (68-159)0.838
 CK-MB (ng/mL), median (IQR)0.5 (0.5-1.1)0.9 (0.6-2.1)< 0.001
 Troponin I (ng/mL), median (IQR)0.04 (0.04-0.04)0.02 (0.01-0.02)< 0.001
 aPTT (seconds), median (IQR)25.9 (23.0-28.7)27.2 (25.0-30.3)< 0.001
 PT (INR), median (IQR)1.06 (1.01-1.11)1.06 (1.01-1.12)0.836
Gastric lavage, n (%)109 (26.4%)22 (10%)< 0.001
Activated charcoal, use n (%)141 (34.1%)0 (0%)< 0.001
SOFA score6 (4-7)5 (3-6)0.153

GCS: Glasgow Coma Scale; WBC: white blood cells; BUN: blood urea nitrogen; AST: aspartate transaminase; ALT: alanine aminotransferase; CRP: C-reactive protein; CK: creatine kinase; CK-MB: creatine kinase-MB; aPTT: activated partial thromboplastin time; PT: prothrombin time; SOFA: sequential organ failure assessment.
Only for ICU patients.